Semaglutide
The most widely used GLP-1 medication for weight loss and type 2 diabetes. Here's how it works, what to expect, and what you need to know before starting.
Semaglutide is an injectable medication that mimics a gut hormone called GLP-1. It helps you feel full sooner, lowers your blood sugar, and can lead to significant weight loss — typically 15–17% of body weight in clinical trials.
Good for you if: You have type 2 diabetes, a BMI over 30 (or 27+ with related health issues), and your doctor recommends medical weight management alongside diet and exercise.
Dive deeper into the researchCommon side effects
- Nausea in 40–50% of users, especially during dose ramp-up
- 25–40% of weight lost may be muscle — resistance training is essential
- Rare but serious: pancreatitis risk (seek emergency care for severe abdominal pain)
What does semaglutide do?
Your gut naturally releases a hormone called GLP-1 after you eat. It tells your brain you're full and signals your pancreas to release insulin. Semaglutide is a synthetic version of this hormone that lasts much longer — about a week — so you only need one injection.
The result: you feel less hungry, eat less naturally, and your blood sugar stays more stable. In clinical trials (the STEP programme), people lost an average of 15–17% of their body weight over about 16 months. That's roughly 15–20 kg for someone weighing 100 kg.
What can you expect?
- Reduced appetite — you feel full sooner and think about food less
- Steady weight loss — most noticeable after 3–6 months
- Better blood sugar control — HbA1c drops of 1–1.5% are typical
- Improved cardiovascular markers — lower triglycerides, blood pressure, and inflammation
- Some GI discomfort — nausea is common early on but usually fades
Who is it for?
Semaglutide is prescribed for two main reasons:
- Type 2 diabetes — as Ozempic (up to 2 mg/week) or Rybelsus (oral, up to 14 mg/day)
- Weight management — as Wegovy (up to 2.4 mg/week), for people with BMI ≥30, or BMI ≥27 with at least one weight-related condition
It's not for type 1 diabetes, and it's not a shortcut — you still need to eat well and stay active. The medication works best alongside lifestyle changes, not instead of them.
How it's taken
Start at 0.25 mg/week for 4 weeks, then increase gradually. Your doctor will titrate up based on how you respond and tolerate each dose. The target is usually 1–2 mg for diabetes or 2.4 mg for weight loss.
Inject once weekly in your stomach, thigh, or upper arm. Same day each week, any time of day. Rotate injection sites.
Important: Never rush the dose increase. If nausea is significant at any dose, stay at that level for an extra 4 weeks before moving up. There's no fixed schedule — titrate at your tolerance.
Storage: Unused pens must stay refrigerated (2–8°C). Once opened, a pen can be kept at room temperature (below 30°C) for up to 56 days. In Indian summers, always transport in an insulated bag with an ice pack.
Availability in India
Semaglutide is available in India under several brand names:
- Ozempic (Novo Nordisk) — injectable, primarily for type 2 diabetes
- Rybelsus — oral tablets, also for type 2 diabetes
- Wegovy — higher-dose injection for weight management (limited availability)
Monthly cost ranges from ₹4,000–₹12,000+ depending on dose and brand. No generics are available in India yet. You'll need a prescription from an endocrinologist or obesity medicine specialist.
Track your GLP-1 biomarkers with eterni
HbA1c, fasting insulin, body composition, and more — monitored over time so you can see if your protocol is working.
Get early accessFrequently Asked Questions
How much weight can you lose on semaglutide?
In the STEP 1 trial, people on the highest dose (2.4 mg/week) lost an average of 15–17% of their body weight over 68 weeks. That's roughly 15–20 kg for someone who weighs 100 kg. Results vary — some people lose more, some less. Diet, exercise, and starting weight all matter.
Is semaglutide available in India?
Yes. Semaglutide is available in India as Ozempic (injection for diabetes), Rybelsus (oral tablets for diabetes), and through some specialty clinics for weight management. Cost ranges from ₹4,000–₹12,000+ per month depending on dose and brand.
What happens when you stop semaglutide?
Most people regain a significant portion of weight within 12 months of stopping — studies show about two-thirds of lost weight returns. This is because the appetite-suppressing effect stops when the drug stops. Building sustainable diet and exercise habits while on the medication is essential.
Does semaglutide cause muscle loss?
Yes. About 25–40% of weight lost on semaglutide is lean mass (muscle and bone), not fat. This is similar to any caloric restriction without exercise. Resistance training 2–3 times per week and protein intake of 1.2–1.6 g/kg/day are essential to minimise this.
How it works in your body
Semaglutide binds to GLP-1 receptors throughout your body. In your brain, it acts on the hypothalamus to reduce hunger signals and food reward. In your pancreas, it stimulates insulin release and suppresses glucagon (the hormone that raises blood sugar). In your gut, it slows gastric emptying — food stays in your stomach longer, which is why you feel full sooner.
It also appears to reduce systemic inflammation, improve lipid profiles, and may have cardiovascular protective effects — the SELECT trial showed a 20% reduction in major cardiovascular events in people with obesity.
Clinical trial data
- STEP 1: 2.4 mg/week produced 14.9% weight loss vs 2.4% placebo over 68 weeks
- STEP 2: In type 2 diabetes, 9.6% weight loss vs 3.4% placebo
- SUSTAIN 6: 26% reduction in major cardiovascular events in type 2 diabetes patients
- SELECT: 20% reduction in heart attack, stroke, and cardiovascular death in people with obesity (without diabetes)
- HbA1c reduction: 1.0–1.8% across diabetes trials
Titration schedule
| Week | Dose | Purpose |
|---|---|---|
| 1–4 | 0.25 mg | Let your body adjust |
| 5–8 | 0.5 mg | Therapeutic effect begins |
| 9–12 | 1.0 mg | Standard diabetes dose |
| 13–16 | 1.7 mg | Higher weight-loss dose |
| 17+ | 2.4 mg | Maximum weight-management dose |
If you experience significant nausea at any step, stay at that dose for an extra 4 weeks. There is no rush — slower titration means fewer side effects and better long-term adherence.
Biomarker monitoring
If you're on semaglutide, track these labs before starting and every 3–6 months:
- HbA1c and fasting glucose — primary diabetes markers
- Fasting insulin and HOMA-IR — insulin sensitivity
- Lipid panel (ApoB, LDL, triglycerides, HDL) — cardiovascular risk
- Liver enzymes (ALT, AST) — semaglutide can improve fatty liver
- Kidney function (creatinine, eGFR) — monitor if dehydration risk
- Vitamin B12 — long-term reduced food intake can lead to deficiency
- Thyroid panel (TSH) — baseline and periodic monitoring
Side effects & safety
Semaglutide has a well-documented side-effect profile. Most side effects are manageable, but some are serious. Here's the complete picture.
Common GI side effects
These are the most frequent adverse events and the leading cause of discontinuation. They result from delayed gastric emptying — a core mechanism of GLP-1 drugs.
| Side Effect | Incidence | Typical Onset | Duration |
|---|---|---|---|
| Nausea | 40–50% | First 1–2 weeks at each dose step | Usually resolves within 4–8 weeks |
| Vomiting | 15–25% | First 2–4 weeks | Improves with dose stabilisation |
| Diarrhoea | 15–30% | Variable | Often self-limiting |
| Constipation | 10–20% | Any phase | May persist; responds to fibre & hydration |
| Abdominal pain | 10–15% | Variable | Usually mild |
How to manage nausea: Slow titration is the single most important tool. Eat small, low-fat meals. Inject in the evening so you sleep through the worst of it. Ginger tea or ginger supplements can reduce nausea by 20–30%. Don't lie down for 2 hours after eating.
Muscle and lean-mass loss
This is the most clinically significant and least discussed side effect. Data from the STEP trials shows that 25–40% of total weight lost on semaglutide is lean mass — muscle, bone, and organ tissue — rather than fat alone.
Resistance training 2–3×/week — provides the anabolic stimulus to preserve muscle even in a caloric deficit
Protein 1.2–1.6 g/kg/day — prioritise protein at every meal (eggs, paneer, dal, whey, tofu)
Creatine monohydrate 3–5 g/day — best-evidenced supplement for preserving lean mass during caloric restriction
Hair loss
Diffuse hair shedding (telogen effluvium) has been reported in 3–6% of users. It's triggered by rapid weight loss rather than a direct drug effect. Hair typically begins shedding 2–4 months after significant weight loss and regrows once weight stabilises. Ensure adequate protein, iron, zinc, and biotin intake.
Facial volume loss ("Ozempic face")
Rapid subcutaneous fat loss from the face can cause a gaunt, aged appearance — especially in people over 40 or those losing more than 10% body weight. Slower weight loss, adequate protein, and collagen-support nutrients (vitamin C, glycine) can help. This happens with any significant rapid weight loss, not just semaglutide.
Serious risks
- Pancreatitis — rare (<0.5%) but serious. Severe abdominal pain radiating to the back requires emergency evaluation. Discontinue if confirmed.
- Gallbladder disease — rapid weight loss increases gallstone formation. 1.5–2× higher rate vs placebo in trials. Watch for right upper-quadrant pain after fatty meals.
- Thyroid C-cell tumours (boxed warning) — seen in rodent studies. Contraindicated if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
- Diabetic retinopathy — rapid glucose improvement can temporarily worsen existing retinopathy
- Acute kidney injury — usually from severe dehydration due to vomiting/diarrhoea. Stay hydrated.
- Severe abdominal pain radiating to the back (possible pancreatitis)
- Persistent vomiting — can't keep fluids down for 24+ hours
- Signs of allergic reaction — facial swelling, hives, difficulty breathing
- Lump or swelling in the neck with difficulty swallowing
- Severe right upper-quadrant pain with fever (possible gallbladder)
Who should not take semaglutide
- Pregnant or breastfeeding women
- Personal or family history of medullary thyroid carcinoma or MEN 2
- Active or history of pancreatitis
- Severe GI disease (gastroparesis)
- Known hypersensitivity to semaglutide
Know what's working. Know what's not.
eterni connects your lab results, medications, and retests — so you can see the trajectory, not just a snapshot.
Join the waitlist